| Officer | Age | In this role | Joined | 2026 pay | Source |
|---|---|---|---|---|---|
|
James C. Clemmer
Also a director
President and Chief Executive Officer
|
61 |
Since 2016
10 years
|
Not stated | $6,060,145 | |
|
Eric Honroth
President and CEO
Title from the Form 4 dated Nov 2, 2026
|
Not stated | Not stated | Not stated | Not reported | |
|
Stephen A. Trowbridge
Executive Vice President and Chief Financial Officer
|
51 |
Since 2020
6 years
|
2008 | $2,661,970 | |
|
Lawrence T. Weiss
Senior Vice President, Chief Legal Officer & Corporate Secretary
|
57 |
Since 2024
2 years
|
Not stated | $1,494,329 | |
|
Chad T. Campbell
Senior Vice President and General Manager, Oncology and Interventional Devices
|
55 | Not stated | 2016 | Not reported | |
|
Laura Piccinini
Senior Vice President and General Manager, Cardiovascular and International
|
56 |
Since 2024
2 years
|
2021 | $1,608,687 | |
|
Warren G. Nighan
Senior Vice President, Global Supply Chain, Quality and Regulatory Affairs
|
57 |
Since 2024
2 years
|
2017 | $1,431,482 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
The proxy filed Oct 8, 2026 states there were none.
Read it in the proxyLoading...